Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis

Diabetes Research and Clinical Practice

Volumn 137, Issue , 2018, Pages 137-148

  Khunti, Kamlesh ^a   Ceriello, Antonio ^b,c   Cos, Xavier ^d,e   De Block, Christophe ^f  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c IRCCS MULTIMEDICA   (Italy)

^d Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^e INSTITUT CATALÀ DE LA SALUT   (Spain)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood glucose; Blood pressure; Cholesterol; Diabetes mellitus, type 2; Guideline adherence; Lipoproteins

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ACHIEVEMENT; BLOOD PRESSURE MEASUREMENT; EUROPE; EVIDENCE BASED PRACTICE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE ORGANIZATION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AMERICA; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); BLOOD; BLOOD PRESSURE; FEMALE; MALE; META ANALYSIS; METABOLISM; PHYSIOLOGY;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINES AS TOPIC; HUMANS; LIPIDS; MALE;

EID: 85041624036     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2017.12.004     Document Type: Review

References (76)

1. Chen, L., Magliano, D.J., Zimmet, P.Z., The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol 8:4 (2012), 228–236.
2. Federation ID, IDF diabetes atlas. 7th ed., 2015, International Diabetes Federation, Brussels, Belgium.
3. Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., Neil, H.A.W., 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:15 (2008), 1577–1589.
4. Hansson, L., Zanchetti, A., Carruthers, S.G., Dahlof, B., Elmfeldt, D., Julius, S., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet (London, England) 351:9118 (1998), 1755–1762.
5. Group TAS, Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362:17 (2010), 1575–1585.
6. Pyorala, K., Pedersen, T.R., Kjekshus, J., Faergeman, O., Olsson, A.G., Thorgeirsson, G., Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:4 (1997), 614–620.
7. Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet 361:9374 (2003), 2005–2016.
8. Colhoun, H.M., Betteridge, D.J., Durrington, P.N., Hitman, G.A., Neil, H.A., Livingstone, S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet (London, England) 364:9435 (2004), 685–696.
9. Stone, M.A., Wilkinson, J.C., Charpentier, G., Clochard, N., Grassi, G., Lindblad, U., et al. Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract 87:2 (2010), 252–260.
10. Soidán, F.J.G., Clinical practice guidelines in type 2 diabetes mellitus: similarities and discrepancies. Med Clin, 135, 2010.
11. Nathan, D.M., Buse, J.B., Davidson, M.B., Heine, R.J., Holman, R.R., Sherwin, R., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes 29:8 (2006), 1963–1972.
12. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 2012;35(6):1364–79.
13. Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38:1 (2015), 140–149.
14. American Diabetes Association, Standards of medical care in diabetes—2017: summary of revisions. Diabetes Care 40:Supplement 1 (2017), S4–S5.
15. Ryden, L., Grant, P.J., Anker, S.D., Berne, C., Cosentino, F., Danchin, N., et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:39 (2013), 3035–3087.
16. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline [NG28]. Available from: https://www.nice.org.uk/guidance/ng28, 2015 Available from:.
17. Ali, M.K., Bullard, K.M., Saaddine, J.B., Cowie, C.C., Imperatore, G., Gregg, E.W., Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368:17 (2013), 1613–1624.
18. Stark Casagrande, S., Fradkin, J.E., Saydah, S.H., Rust, K.F., Cowie, C.C., The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 36:8 (2013), 2271–2279.
19. Stone, M.A., Khunti, K., Charpentier, G., Doggen, K., Kuss, O., Lindblad, U., et al. Quality of care of people with type 2 diabetes in eight European Countries: findings from the guideline adherence to enhance care (GUIDANCE) study. Diabetes Care 36:9 (2013), 2628–2638.
20. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clin Res ed.), 339, 2009, b2535.
21. Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012.
22. Andrade JF, Silva V, Melnik T. Mulberry therapy for type 2 diabetes mellitus. Cochrane Database Syst Rev 2015(5).
23. Ferket, B.S., Colkesen, E.B., Visser, J.J., Spronk, S., Kraaijenhagen, R.A., Steyerberg, E.W., et al. Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?. Arch Intern Med 170:1 (2010), 27–40.
24. Ferket BS, Grootenboer N, Colkesen EB, Visser JJ, van Sambeek MRHM, Spronk S, et al. Systematic review of guidelines on abdominal aortic aneurysm screening. J Vasc Surg 55(5):1296–1304.e4.
25. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7:3 (1986), 177–188.
26. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ (Clin Res ed.) 327:7414 (2003), 557–560.
27. Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (Clin Res ed.) 2011;343.
28. Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res ed.) 315:7109 (1997), 629–634.
29. DerSimonian, R., Kacker, R., Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:2 (2007), 105–114.
30. Schwarzer G, Schwarzer MG. Package ‘meta’. Available from: https://cran.r-project.org/web/packages/meta/meta.pdf; 2016.
31. Viechtbauer W. Package ‘metafor’. Available from: https://cran.r-project.org/web/packages/metafor/metafor.pdf; 2016.
32. Stark, R.G., Schunk, M.V., Leidl, R., Holle, R., Meisinger, C., Rathmann, W., Medical care of type 2 diabetes in German Disease Management Programmes: a population-based evaluation. Diabetes/Metab Res Rev 27:4 (2011), 383–391.
33. Davidson, J., Koro, C., Arondekar, B., Lee, B.H., Fedder, D., A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients. Clin Ther 30:2 (2008), 287–293.
34. Bala, M.M., Placzkiewicz-Jankowska, E., Lesniak, W., Topor-Madry, R., Michalejko, M., Jankowski, M., et al. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study. Pol Arch Med Wewn 123:11 (2013), 573–581.
35. Bala, M.M., Lesniak, W., Placzkiewicz-Jankowska, E., Topor-Madry, R., Jaeschke, R., Sieradzki, J., et al. Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study. Kardiologia polska 69:12 (2011), 1249–1257.
36. Bala, M.M., Placzkiewicz-Jankowska, E., Topor-Madry, R., Lesniak, W., Jaeschke, R., Sieradzki, J., et al. Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study. Pol Arch Med Wewn 121:1–2 (2011), 7–17.
37. Miñambres, I., Mediavilla, J.J., Sarroca, J., Pérez, A., Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain. BMC Endocr Disord, 16, 2016, 10.
38. Vaccaro, O., Boemi, M., Cavalot, F., De Feo, P., Miccoli, R., Patti, L., et al. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis 198:2 (2008), 396–402.
39. Leśniak, W., Bała, M.M., Płaczkiewicz-Jankowska, E., Topór-Mądry, R., Jankowski, M., Sieradzki, J., et al. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study. Cardiol J 22:2 (2015), 150–159.
40. Bala, M.M., Placzkiewicz-Jankowska, E., Lesniak, W., Topor-Madry, R., Jankowski, M., Grzeszczak, W., et al. Management and treatment goals in Polish patients with type 2 diabetes of more than ten years' duration – results of ARETAEUS2-Grupa Study. Endokrynologia Polska 65:3 (2014), 158–168.
41. Al-Taweel, D.M., Awad, A.I., Johnson, B.J., Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait. Int J Clin Pharm 35:2 (2013), 244–250.
42. Issam Diab, M., Julienne Johnson, B., Hudson, S., Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar. Int J Clin Pharm 35:1 (2013), 101–112.
43. Mafauzy, M., Hussein, Z., Chan, S.P., The status of diabetes control in Malaysia: results of Diabcare 2008. Med J Malaysia 66:3 (2011), 175–181.
44. Latif, Z.A., Jain, A., Rahman, M.M., Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008. Bangladesh Med Res Counc Bull 37:1 (2011), 11–16.
45. Jimeno CA, Sobrepena LM, Mirasol RC. DiabCare 2008: Survey on glycaemic control and the status of diabetes care and complications among patients with type 2 diabetes mellitus in the Philippines. Phillippine J Intern Med 2012;50(2).
46. American Diabetes Association, Standards of medical care in diabetes–2006. Diabetes Care, 29(suppl 1), 2005, s4.
47. Rao, D.T., Sunio, L.K., Lo, Y.-J., Gossain, V.V., Comparison of the adherence to the american diabetes association guidelines of diabetes care in primary care and subspecialty clinics. J Diabet Metab Disord, 14(1), 2015, 35.
48. Cahill S, Liew A, O'Brien T. American diabetes association recommendation adherence among patients attending the adult diabetes clinic in Galway University Hospital. Irish J Med Sci 2010;179(13).
49. Al Harbi, T.J., Tourkmani, A.M., Al-Khashan, H.I., Mishriky, A.M., Al Qahtani, H., Bakhiet, A., Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia. Saudi Med J 36:2 (2015), 221–227.
50. Ali, D., Abduelkarem, A., Shahwan, M., Evaluation of factors associated with inadequate glycemic control and some other health care indicators among patients with type 2 diabetes in Ramallah, Palestine. Res J Pharmaceut, Biol Chem Sci 4:3 (2013), 445–451.
51. Meyer, D., Wirrig, M., Heh, V., Shubrook, J., Comanagement of elderly patients with type 2 diabetes: better adherence to ADA guidelines?. Osteopathic Family Phys 2:6 (2010), 160–164.
52. Rodríguez, A., Calle, A., Vázquez, L., Chacón, F., Polavieja, P., Reviriego, J., et al. Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study. Diabetic Med: J Brit Diabet Assoc 28:6 (2011), 731–740.
53. UK Prospective Diabetes Study Group, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ (Clin Res ed.) 317:7160 (1998), 713–720.
54. World Health Organisation. Global Report on Diabetes. Available from: http://www.who.int/diabetes/global-report/en/; 2016.
55. Wild, S., Roglic, G., Green, A., Sicree, R., King, H., Global prevalence of diabetes. Diabetes Care, 27(5), 2004, 1047.
56. Oellgaard, J., Gaede, P., Rossing, P., Persson, F., Parving, H.H., Pedersen, O., Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. Kidney Int 91:4 (2017), 982–988.
57. Gæde, P., Oellgaard, J., Carstensen, B., Rossing, P., Lund-Andersen, H., Parving, H.-H., et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia 59:11 (2016), 2298–2307.
58. O'Connor, P.J., Crabtree, B.F., Yanoshik, M.K., Differences between diabetic patients who do and do not respond to a diabetes care intervention: a qualitative analysis. Fam Med 29:6 (1997), 424–428.
59. Grant, R.W., Pabon-Nau, L., Ross, K.M., Youatt, E.J., Pandiscio, J.C., Park, E.R., Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines. Diabetes Educ 37:1 (2011), 78–84.
60. Farquhar, C.M., Kofa, E.W., Slutsky, J.R., Clinicians' attitudes to clinical practice guidelines: a systematic review. Med J Australia 177:9 (2002), 502–506.
61. Cranney, M., Warren, E., Barton, S., Gardner, K., Walley, T., Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract 18:4 (2001), 359–363.
62. Carlsen, B., Glenton, C., Pope, C., Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines. Brit J Gen Pract: J R Coll Gen Practition 57:545 (2007), 971–978.
63. Cahn, A., Raz, I., Kleinman, Y., Balicer, R., Hoshen, M., Lieberman, N., et al. Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists. Diabetes Care 38:12 (2015), 2293–2300.
64. Larme, A.C., Pugh, J.A., Evidence-based guidelines meet the real world. Case Diabet Care 24:10 (2001), 1728–1733.
65. Hermans, M.P., Elisaf, M., Michel, G., Muls, E., Nobels, F., Vandenberghe, H., et al. Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial. Diabetes Care 36:11 (2013), 3388–3395.
66. Prior, M., Guerin, M., Grimmer-Somers, K., The effectiveness of clinical guideline implementation strategies–a synthesis of systematic review findings. J Eval Clin Pract 14:5 (2008), 888–897.
67. Comin E, Catalan-Ramos A, Iglesias-Rodal M, Grau M, Del Val JL, Consola A, et al. Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors: a pre-post controlled study. Atencion primaria 2017.
68. Simmons, R.K., Bruun, N.H., Witte, D.R., Borch-Johnsen, K., Jorgensen, M.E., Sandbaek, A., et al. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in ‘at risk’ individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial. Diabetologia 60:6 (2017), 1016–1021.
69. Ament SMC, de Groot JJA, Maessen JMC, Dirksen CD, van der Weijden T, Kleijnen J. Sustainability of professionals’ adherence to clinical practice guidelines in medical care: a systematic review. BMJ Open 2015;5(12).
70. Ji, L.-N., Lu, J.-M., Guo, X.-H., Yang, W.-Y., Weng, J.-P., Jia, W.-P., et al. Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Publ Health, 13, 2013 602-02.
71. Woodard, L.D., Urech, T., Landrum, C.R., Wang, D., Petersen, L.A., Impact of comorbidity type on measures of quality for diabetes care. Med Care 49:6 (2011), 605–610.
72. Engel, J., Damen, N.L., van der Wulp, I., de Bruijne, M.C., Wagner, C., Adherence to cardiac practice guidelines in the management of non-st-elevation acute coronary syndromes: a systematic literature review. Curr Cardiol Rev 13:1 (2017), 3–27.
73. Dunkley, A.J., Bodicoat, D.H., Greaves, C.J., Russell, C., Yates, T., Davies, M.J., et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations. Diabetes Care, 37(4), 2014, 922.
74. Lian, J., Liang, Y., Diabetes management in the real world and the impact of adherence to guideline recommendations. Curr Med Res Opin 30:11 (2014), 2233–2240.
75. Wong, N.D., Patao, C., Wong, K., Malik, S., Franklin, S.S., Iloeje, U., Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status. Diabetes Vasc Dis Res 10:6 (2013), 505–513.
76. Sriwijitkamol A, Moungngern Y, Vannaseang S. Attainment of American Diabetes Association clinical practice recommendations in 722 Thai type 2 diabetes patients. J Med Assoc Thailand = Chotmaihet thangphaet 2011;94.